Massimo Gion

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Topics

Randomized Controlled Trial

Room Temperature

Metastatic Breast Cancer

Clinical Practice

Top Venues

The International journal of biological markers

Clinical chemistry and laboratory medicine

Journal of evaluation in clinical practice

Risk management and healthcare policy

This page only lists publications with an associated author ORCID identifier.

Publications

Elia Cappelletto, Laura Tiozzo Fasiolo, Valentina Salizzato, Luisa Piccin, Alessio Fabozzi, Anna Contato, Paola Del Bianco, Giulia Pasello, Vanna Chiarion-Sileni, Massimo Gion, Aline S C Fabricio
Cytokine and soluble programmed death-ligand 1 levels in serum and plasma of cancer patients treated with immunotherapy: Preanalytical and analytical considerations. The International journal of biological markers 39 (1) (2024)
Massimo Gion, Roberto De Gobbi, Manuel Zorzi, Giovanni Carretta, Luca Leonardi, Stefano Guzzinati, Chiara Trevisiol, Maurizio Cancian, Giulia Cardinali, Federica Michieletto, Ruggero Dittadi, Aline S C Fabricio, Massimo Rugge, Francesca Russo
Overordering of tumor marker for outpatients revealed by performance indicators and the impact of a health policy intervention: An observational study using administrative records. The International journal of biological markers (2023)
Massimo Gion, Roberto De Gobbi, Manuel Zorzi, Giovanni Carretta, Luca Leonardi, Stefano Guzzinati, Chiara Trevisiol, Maurizio Cancian, Giulia Cardinali, Federica Michieletto, Ruggero Dittadi, Aline S C Fabricio, Massimo Rugge, Francesca Russo
Overordering of tumor marker for outpatients revealed by performance indicators and the impact of a health policy intervention: An observational study using administrative records. The International journal of biological markers (2023)
Massimo Gion, Giulia Cardinali, Stefano Guzzinati, Paolo Morandi, Chiara Trevisiol, Aline S C Fabricio, Massimo Rugge, Manuel Zorzi
Use of Routine Health Datasets to Assess the Appropriateness of Diagnostic Tests in the Follow-Up of Breast Cancer Patients: A Population-Based Study on 3930 Patients. Risk management and healthcare policy 15 (2022)
Ruggero Dittadi, Aline S C Fabricio, Massimo Gion
Biological variation and reference change value as decision criteria in clinical use of tumor biomarkers. Are they really useful? Clinical chemistry and laboratory medicine 60 (6) (2022)
Valentina Agnolon, Anna Contato, Anna Meneghello, Elda Tagliabue, Giuseppe Toffoli, Massimo Gion, Federico Polo, Aline S C Fabricio
ELISA assay employing epitope-specific monoclonal antibodies to quantify circulating HER2 with potential application in monitoring cancer patients undergoing therapy with trastuzumab. Scientific reports 10 (1) (2020)
Aline S C Fabricio, Silvia Michilin, Matelda Zancan, Valentina Agnolon, Lucia Peloso, Ruggero Dittadi, Antonio Scapinello, Claudio Ceccarelli, Massimo Gion
Shed HER2 surrogacy evaluation in primary breast cancer patients: a study assessing tumor tissue HER2 expression at both extracellular and intracellular levels. Scandinavian journal of clinical and laboratory investigation 79 (4) (2019)
Ruggero Dittadi, Aline S C Fabricio, Giulia Rainato, Edoardo Peroni, Fulvio Di Tonno, Beatrice Vezzù, Chiara Mazzariol, Elisa Squarcina, Laura Tammone, Massimo Gion
Preanalytical stability of [-2]proPSA in whole blood stored at room temperature before separation of serum and plasma: implications to Phi determination. Clinical chemistry and laboratory medicine 57 (4) (2019)
Chiara Trevisiol, Michela Cinquini, Aline S C Fabricio, Massimo Gion, Anne W S Rutjes
Insufficient uptake of systematic search methods in oncological clinical practice guideline: a systematic review. BMC medical research methodology 19 (1) (2019)
Massimo Gion, Giulia Cardinali, Chiara Trevisiol, Marco Zappa, Giulia Rainato, Aline S C Fabricio
Indicators of inappropriate tumour marker use through the mining of electronic health records. Journal of evaluation in clinical practice 23 (4) (2017)